The Biosimilars Initiative in British Columbia, Canada, mandated patients with certain conditions on the province’s prescription coverage plan to switch from originator etanercept to a biosimilar. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback